Wyeth More Optimistic About Medicare Rx; Protonix May Benefit
Executive Summary
Wyeth is becoming more optimistic about the potential upside of the Medicare prescription drug benefit, Wyeth North America President Joseph Mahady said during the Smith Barney Citigroup Healthcare Conference in Washington, D.C. March 30
You may also be interested in...
Lilly’s Zyprexa, Cymbalta Will Be Dropped From Florida Medicaid Drug List
Florida Medicaid will reconsider the status of GlaxoSmithKline's Paxil, Forest's Lexapro and Pfizer's Zoloft on the state's preferred drug list in September after awarding the antidepressants conditional placement on the PDL
Lilly’s Zyprexa, Cymbalta Will Be Dropped From Florida Medicaid Drug List
Florida Medicaid will reconsider the status of GlaxoSmithKline's Paxil, Forest's Lexapro and Pfizer's Zoloft on the state's preferred drug list in September after awarding the antidepressants conditional placement on the PDL
No News Is Good News For Wyeth: Smooth Quarter Will Beat Expectations
A lack of "negative surprises" for Wyeth during the first quarter is contributing to financial results well above analyst estimates, the company said